华夏医疗健康混合C(000946)利润分配表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 收入 |
184,337,528.15 |
192,628,359.62 |
-136,593,881.97 |
-147,004,925.51 |
| 利息合计 |
295,414.39 |
154,969.90 |
387,237.63 |
187,261.05 |
| 其中:存款利息收入 |
295,414.39 |
154,969.90 |
369,187.83 |
169,211.25 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
18,049.80 |
18,049.80 |
| 投资收益合计 |
157,373,209.67 |
32,151,794.78 |
-119,406,930.98 |
-99,363,205.53 |
| 其中:股票投资收益 |
149,393,811.06 |
26,269,227.55 |
-133,776,182.62 |
-109,692,200.58 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
913,012.95 |
437,375.34 |
1,245,624.01 |
575,836.06 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
7,066,385.66 |
5,445,191.89 |
13,123,627.63 |
9,753,158.99 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
26,250,547.98 |
160,183,219.94 |
-17,717,795.50 |
-47,871,616.70 |
| 其他收入 |
418,356.11 |
138,375.00 |
143,606.88 |
42,635.67 |
| 费用 |
16,087,245.35 |
7,763,245.48 |
16,271,556.28 |
8,416,703.04 |
| 管理人报酬 |
12,708,671.72 |
6,133,354.35 |
12,828,737.42 |
6,633,384.50 |
| 基金托管费 |
2,118,111.96 |
1,022,225.79 |
2,138,122.93 |
1,105,564.11 |
| 销售服务费 |
1,047,557.79 |
506,967.48 |
1,091,364.95 |
568,951.29 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
212,903.88 |
100,697.86 |
213,330.66 |
108,803.14 |
| 利润总额 |
168,250,282.80 |
184,865,114.14 |
-152,865,438.25 |
-155,421,628.55 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年